Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1 10Phase NA 9Phase 1/2 5Phase 4 2Phase 2/3 1

Status

Completed 10Unknown 3Terminated 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Breast Neoplasms 18Neoplasms 16Prostatic Neoplasms 12Neoplasm Metastasis 10Pain 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Polycystic Ovary Syndrome 7Leiomyoma 6Anemia 5Skin Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 4Carcinoma, Renal Cell 4Recurrence 3Melanoma 3Liver Neoplasms 3Kidney Neoplasms 3Keratosis, Actinic 3Insulin Resistance 3Carcinoma, Hepatocellular 3Cancer Pain 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2

Interventions

Thyroxine 1Technetium Tc 99m Sestamibi 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Thyroid Neoplasms × Clear all
NCT03065218 2022-07-26

99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients

Medstar Health Research Institute

Phase 4 Terminated
4 enrolled 5 charts
Head & Neck

Thyroid Diseases, Thyroid Neoplasms

NCT02946918 2020-12-01

Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy

University of Texas Southwestern Medical Center

Phase 4 Terminated
14 enrolled 9 charts
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡